Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)
I. O. Stoma, E. V. Voropaev, E. I. Mikhailova et al. · Эпидемиология и вакцинопрофилактика · 2024
Abstract onlyNot checked